Professor
Oxford Centre for Clinical Magnetic Resonance Research, United Kingdom
Stefan Neubauer is a Professor of Cardiovascular Medicine, Head of the Division of Cardiovascular Medicine and Director of the Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, John Radcliffe Hospital, United Kingdom. Prof. Neubauer’s work over the past 35 years has been devoted to the development and application of Cardiovascular Magnetic Resonance (CMR) imaging and spectroscopy, and, in recent years, also to the development of novel coronary CT imaging. He has attracted over £200m in research funding, has published >700 original research articles and currently leads a group of ~50 co-workers. He has supervised over 50 PhD/MD students, who have won >30 young investigator awards. Editorial positions and contributions to scientific bodies include his involvement with the Society for Cardiovascular Magnetic Resonance (President 2006-2007), Chairman of the British Society of Cardiovascular Magnetic Resonance (2008-2010), International Associate Editor of the European Heart Journal (2010-2020), Associate Editor of the Journal of Cardiovascular Magnetic Resonance. Awards and Honours include the American Heart Association Paul Dudley White International Lectureship Award 2005, the British Cardiovascular Society Thomas Lewis Lecture 2008, National Institute for Health Research Senior Investigator Award 2010, the European Magnetic Resonance Award 2010, the SCMR Gold Medal 2013, the RT Hall Lecture 2017, the European Society of Cardiology Innovation Lecture (2022) and the European Society of Cardiology Silver Medal (2022). He is a fellow of the UK Academy of Medical Sciences and is the leader of the Imaging Theme for the Oxford NIHR Biomedical Research Centre. He is also a founder of two University spinout companies, Perspectum (developing novel liver imaging) and Caristo Diagnostics (developing novel coronary CT imaging).
Wednesday, January 29, 2025
9:35 AM – 9:45 AM East Coast USA Time
Beyond outflow obstruction alleviation in HOCM: Role of CMR in monitoring cardiac myosin inhibitors.
Thursday, January 30, 2025
2:20 PM – 2:30 PM East Coast USA Time
Thursday, January 30, 2025
3:10 PM – 3:20 PM East Coast USA Time
Exercise CMR and proteomic characterization of HFpEF across the spectrum of LV ejection fraction
Thursday, January 30, 2025
5:10 PM – 5:20 PM East Coast USA Time
Friday, January 31, 2025
11:00 AM – 11:10 AM East Coast USA Time
Keynote: CMR and CCT for the coming decade: Potential game-changers
Friday, January 31, 2025
5:20 PM – 5:40 PM East Coast USA Time
Oral Abstract Clinical #3- Transformative Cardiac MRI Research
Saturday, February 1, 2025
10:50 AM – 11:50 AM East Coast USA Time
Saturday, February 1, 2025
11:10 AM – 11:20 AM East Coast USA Time
Saturday, February 1, 2025
11:40 AM – 11:50 AM East Coast USA Time